Petpal Pet Nutrition Technology Co., Ltd.

SZSE:300673.SZ

13.1 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 459.926384.361494.792423.838334.072158.582377.19508.549502.733343.331355.648203.838390.614320.792367.881390.27340.545241.152308.885299.233238.063162.129259.441216.024233.197160.66208.791154.525161.679107.002162.959130.138154.811102.664147.499147.499101.198101.198111.29111.2987.42587.425
Cost of Revenue 335.018290.734376.061345.812280.248136.314327.689396.939362.314258.668305.252141.116282.66250.435290.831273.136241.755192.335235.959233.516177.579109.504164.559139.074161.504101.997119.88895.467108.13572.945111.98888.781116.35772.215105.695105.69574.93774.93784.17484.17466.98266.982
Gross Profit 124.90893.627118.73178.02653.82522.26849.501111.61140.41984.66250.39662.722107.95470.35777.05117.13498.79148.81772.92665.71760.48452.62494.88276.9571.69358.66488.90359.05953.54434.05750.97141.35738.45430.4541.80441.80426.26126.26127.11627.11620.44420.444
Gross Profit Ratio 0.2720.2440.240.1840.1610.140.1310.2190.2790.2470.1420.3080.2760.2190.2090.30.290.2020.2360.220.2540.3250.3660.3560.3070.3650.4260.3820.3310.3180.3130.3180.2480.2970.2830.2830.260.260.2440.2440.2340.234
Reseach & Development Expenses 9.1354.8117.5058.9588.4994.0758.4635.2018.9856.1676.7086.0025.2844.6627.4997.3248.1533.1986.797.9936.0915.0469.7927.0884.8734.05720.07808.311016.72500000004.9734.9733.6273.627
General & Administrative Expenses -5.67224.35-39.27959.029-1.927.441-57.87579.309-7.60422.788-50.60662.821-9.7424.624-39.20821.671-4.87920.066-33.77130.7476.41326.38-16.97420.61-8.11619.42-26.01816.833-7.81713.392-25.80111.903-3.86210.48917.76117.76112.52812.52812.02912.02910.08410.084
Selling & Marketing Expenses 33.02217.83636.78522.18126.27516.98125.86524.80221.21714.72113.43811.26816.31613.876-4.95823.10124.45814.76729.74817.38212.868.91715.82411.40510.1396.1596.0347.6795.9733.6825.1535.3584.2062.8874.9134.9132.8792.8793.763.763.2523.252
SG&A 59.8942.186-2.49481.2124.37544.422-32.01104.11213.61237.509-37.16874.0896.57638.5-44.16644.77219.57934.833-4.02348.12919.27335.297-1.15132.0152.02325.579-19.98424.512-1.84417.074-20.64817.2610.34513.37622.67422.67415.40615.40615.54115.54113.33613.336
Other Expenses -0.224-0.237-0.244-2.2782.212-0.232-1.35-1.257-2.35-0.238-0.196-0.266-0.23-0.295-0.868-0.199-0.7790.0130.803-0.0980.069-0.17.3840.07-0.81-0.0210.951-0.046-0.5370.4282.2540.6670.0610.0900000000
Operating Expenses 69.02647.70571.18558.7766.59249.32560.77667.48970.3939.43251.5545.62546.8843.94628.3349.91752.64337.03456.69456.75244.72440.85862.04937.83434.00618.81236.12725.42920.85418.16727.54519.20920.14714.43319.14319.14315.12115.12117.17917.17913.24813.248
Operating Income 55.88250.06429.13715.079-3.611-37.36-27.98682.56178.75835.509-18.03416.91651.48328.79936.95245.65938.18515.47619.15111.07519.388.46433.17642.49746.10435.08651.74327.87428.37615.55928.73422.76919.78115.17417.41517.41510.85510.85510.54310.5436.3646.364
Operating Income Ratio 0.1220.130.0590.036-0.011-0.236-0.0740.1620.1570.103-0.0510.0830.1320.090.10.1170.1120.0640.0620.0370.0810.0520.1280.1970.1980.2180.2480.180.1760.1450.1760.1750.1280.1480.1180.1180.1070.1070.0950.0950.0730.073
Total Other Income Expenses Net 9.401-0.237-0.244-0.1350.07-0.2320.792-1.257-2.35-0.238-0.6-0.006-0.49-0.295-0.868-0.199-0.7790.0130.803-0.0980.069-0.17.3840.07-0.81-0.0211.125-0.219-0.5370.4282.1320.6670.0610.095.3825.3820.2960.296-1.013-1.0130.4520.452
Income Before Tax 65.28349.82628.89314.944-3.541-37.592-27.19481.30476.40735.271-18.63416.9150.99328.50536.08445.45937.40615.4919.95410.97819.4498.36440.5642.56745.29435.06552.86827.65527.83915.98730.86623.43619.84215.26422.79722.79711.15111.1519.5299.5296.8166.816
Income Before Tax Ratio 0.1420.130.0580.035-0.011-0.237-0.0720.160.1520.103-0.0520.0830.1310.0890.0980.1160.110.0640.0650.0370.0820.0520.1560.1970.1940.2180.2530.1790.1720.1490.1890.180.1280.1490.1550.1550.110.110.0860.0860.0780.078
Income Tax Expense 8.6167.97114.731.8011.7790.3613.71512.1614.4386.188-0.3572.9348.4764.6644.4145.5325.1382.7712.0061.5961.4531.1462.5827.3666.8755.2266.9934.4243.5192.5141.9023.7171.8832.7583.483.481.5021.5021.2331.2331.2361.236
Net Income 56.22641.71218.06913.538-4.624-38.073-30.77867.46361.88928.549-18.66613.72741.5823.37731.8339.71531.5111.77118.8948.18116.796.14136.99735.15238.19929.95945.7923.15424.20713.61128.93819.66417.95712.48219.47919.4799.6299.6298.5028.5025.5755.575
Net Income Ratio 0.1220.1090.0370.032-0.014-0.24-0.0820.1330.1230.083-0.0520.0670.1060.0730.0870.1020.0930.0490.0610.0270.0710.0380.1430.1630.1640.1860.2190.150.150.1270.1780.1510.1160.1220.1320.1320.0950.0950.0760.0760.0640.064
EPS 0.230.170.0730.054-0.019-0.15-0.120.270.250.11-0.0740.0540.160.090.140.160.110.0530.0880.0140.0820.0270.170.190.180.210.180.120.150.0850.180.120.120.0780.120.120.0610.0610.0560.0560.0350.035
EPS Diluted 0.230.170.0730.054-0.019-0.15-0.120.270.250.11-0.0740.0540.160.090.140.160.110.0530.0880.0140.0820.0270.170.190.180.210.180.120.150.0850.180.120.120.0780.120.120.0610.0610.0560.0560.0350.035
EBITDA 74.12959.39943.21824.0578.702-33.591-33.58481.06992.64249.197-8.8319.76554.48630.80632.71654.93445.30915.36116.0717.43521.4888.0541.8244.47243.4539.85344.08635.5628.95414.6134.96622.58320.63615.54718.30918.30911.83811.83811.83511.8357.3637.363
EBITDA Ratio 0.1610.1550.0870.0570.026-0.212-0.0890.1590.1840.143-0.0250.0480.1390.0960.0890.1410.1330.0640.0520.0580.090.050.1610.2060.1860.2480.2110.230.1790.1370.2150.1740.1330.1510.1240.1240.1170.1170.1060.1060.0840.084